Latest News & Features
Americas
A US court has ruled that two patents covering the Repatha drug, owned by biotechnology company Amgen, are valid. 18 March 2016
Americas
Law firm Perkins Coie has hired Mark Wicker as a partner in the firm’s technology transactions and privacy practice in San Diego. 18 March 2016
Americas
The US Federal Trade Commission has urged a federal appeals court to correct errors in a judgment from a Pennsylvania court that found the plaintiff in a pay-for-delay case had failed to prove that the agreement breached US competition law. 17 March 2016
Big Pharma
Pharmaceutical company GSK has announced to shareholders that its chief executive Sir Andrew Witty will be retiring from his role in 2017. 17 March 2016
Americas
The Patent Trial and Appeal Board has instituted trials on four patents owned by Acorda Therapeutics following challenges from the Coalition for Affordable Drugs and hedge fund manager Kyle Bass. 16 March 2016
Americas
Law firm Proskauer Rose has expanded its life sciences patent practice by hiring Fangli Chen as a partner and Daniel Klein as a senior patent counsel. 16 March 2016
Asia
Activist organisation Médecins Sans Frontières has challenged Pfizer’s patent application covering the pneumococcal conjugate vaccine on the grounds that it is obvious. 15 March 2016
Asia
A Switzerland-based drug licensing agency has warned that counterfeit packs of hepatitis C drug Harvoni have been imported into Switzerland. 14 March 2016
Americas
The Patent Trial and Appeal Board has rejected three inter partes reviews filed by Kyle Bass’s organisation the Coalition for Affordable Drugs. 11 March 2016
Americas
The US Patent and Trademark Office has opened proceedings to determine who owns the rights to the CRISPR/Cas9 technology. 11 March 2016